APA (7th ed.) Citation

AF, d. R., PS, P. J., GS, C., GF, M., HK, M., TL, M., . . . AJF, C. (2021). Growth hormone directly favors hepatic ketogenesis in persons with prediabetes or type 2 diabetes mellitus treated with empagliflozin. Endocrine, 73(2), 325. https://doi.org/10.1007/s12020-021-02730-0

Chicago Style (17th ed.) Citation

AF, da Rocha, Pereira Junior PS, Calefi GS, Marquezine GF, Morimoto HK, Mazzuco TL, de Faria EC, Urbano MR, and Carrilho AJF. "Growth Hormone Directly Favors Hepatic Ketogenesis in Persons with Prediabetes or Type 2 Diabetes Mellitus Treated with Empagliflozin." Endocrine 73, no. 2 (2021): 325. https://doi.org/10.1007/s12020-021-02730-0.

MLA (9th ed.) Citation

AF, da Rocha, et al. "Growth Hormone Directly Favors Hepatic Ketogenesis in Persons with Prediabetes or Type 2 Diabetes Mellitus Treated with Empagliflozin." Endocrine, vol. 73, no. 2, 2021, p. 325, https://doi.org/10.1007/s12020-021-02730-0.